4.7 Article

Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation

Related references

Note: Only part of the references are listed.
Article Cell Biology

Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits

Amit K. Mitra et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)

Review Hematology

Chemokines in Vascular Dysfunction and Remodeling

Andreas Schober

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)

Review Cardiac & Cardiovascular Systems

Cytokines and atherosclerosis: a comprehensive review of studies in mice

Robert Kleemann et al.

CARDIOVASCULAR RESEARCH (2008)

Article Cardiac & Cardiovascular Systems

PTEN reduces cuff-induced neointima formation and proinflammatory cytokines

Shinichiro Koide et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

An essential role for gp130 in neointima formation following arterial injury

Dong Wang et al.

CIRCULATION RESEARCH (2007)

Review Pathology

In stent restenosis: bane of the stent era

AK Mitra et al.

JOURNAL OF CLINICAL PATHOLOGY (2006)

Article Cardiac & Cardiovascular Systems

SDF-1α/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells

A Zernecke et al.

CIRCULATION RESEARCH (2005)

Article Hematology

Adenovirus-mediated Intraarterial delivery of PTEN inhibits neointimal hyperplasia

J Huang et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)

Review Cardiac & Cardiovascular Systems

Nuclear factor κB:: a potential therapeutic target in atherosclerosis and thrombosis

C Monaco et al.

CARDIOVASCULAR RESEARCH (2004)

Article Cell Biology

The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation

KA Martin et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)

Article Multidisciplinary Sciences

Restricted inactivation of serum response factor to the cardiovascular system

JM Miano et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Cardiac & Cardiovascular Systems

Chemokines in the pathogenesis of vascular disease

IF Charo et al.

CIRCULATION RESEARCH (2004)

Article Cardiac & Cardiovascular Systems

Regulation of SM22α expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells

N Kaplan-Albuquerque et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)

Article Hematology

Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN

JH Huang et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)

Review Biochemistry & Molecular Biology

Missing pieces in the NF-κB puzzle

S Ghosh et al.

Article Biochemistry & Molecular Biology

Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFκB activation without interfering with the IκB degradation pathway

D Koul et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Review Biochemistry & Molecular Biology

Atherosclerosis: The road ahead

CK Glass et al.

Article Medicine, Research & Experimental

NF-κB:: pivotal mediator or innocent bystander in atherogenesis?

T Collins et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)

Review Oncology

PTEN, a unique tumor suppressor gene

PLM Dahia

ENDOCRINE-RELATED CANCER (2000)

Article Pathology

Strain-dependent vascular remodeling phenotypes in inbred mice

KJ Harmon et al.

AMERICAN JOURNAL OF PATHOLOGY (2000)